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Abstract: A novel serine protease inhibitor (serpin) gene designated as Spi1C was cloned 
via the sequenced-based screening of a metagenomic library from uncultured marine 
microorganisms. The gene had an open reading frame of 642 base pairs, and encoded a 
214-amino acid polypeptide with a predicted molecular mass of about 28.7 kDa. The 
deduced amino acid sequence comparison and phylogenetic analysis indicated that Spi1C 
and some partial proteinase inhibitor I4 serpins were closely related. Functional 
characterization demonstrated that the recombinant Spi1C protein could inhibit a series of 
serine proteases. The Spi1C protein exhibited inhibitory activity against α-chymotrypsin and 
trypsin with Ki values of around 1.79 × 10
−8 and 1.52 × 10
−8 M, respectively. No inhibition 
activity was exhibited against elastase. Using H-D-Phe-Pip-Arg-pNA as the chromogenic 
substrate, the optimum pH and temperature of the inhibition activity against trypsin were 
7.0–8.0 and 25 °C, respectively. The identification of a novel serpin gene underscores the 
potential of marine metagenome screening for novel biomolecules. 
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1. Introduction  
Serine protease inhibitors (serpins) are the largest and most important superfamily of protease 
inhibitors. They act as suicide substrates by covalently binding to their target protease, leading to 
inactivation [1]. Serpins have been found in abundance in eukaryotes, and even in some bacteria as well 
as archea [2]. Serpins are very interesting because they act as modulators, playing key roles in regulating 
the activities of numerous serine and cysteine proteases. Serpins control complement activation and a 
variety of other physiological functions, such as blood coagulation, fibrinolysis, inflammation, tumor 
cell metastasis, apoptosis, and others [3]. Interestingly, several human serpins and those of other 
organisms have evolved functions that do not involve protease inhibition [4,5]. 
The roles of these serpins are being elucidated in animal models of disease. Clearly, many serpins not 
only inhibit proteases, but also have other physiological effects induced by their interactions with other 
molecules. These interactions reinforce a particular physiological response [6]. The structure and 
function of serpins enable them to provide novel scaffolds for engineering protease inhibitors of desired 
specificity for therapeutic use [7]. Some individual serpins can even efficiently inhibit more than one 
class of proteases [8]. The structure and properties of serine proteases in covalent complexes are still 
somewhat uncertain. Studies on the structures of serpin complexes with target proteases are limited, and 
are mostly focused on complexes with caspases [9,10]. Novel serpin engineering shows considerable 
potential in creating novel therapeutics that can normalize dysfunctional proteases [11]. The exploration 
of novel serpins from uncultured microorganisms via genetic biotechnology is interesting. These serpins 
may be used in candidate antigen gene tests and immunoassays [12]. 
Metagenomics is a powerful tool for assessing genetic information from uncultured microorganisms. 
Metagenomics consists of the extraction, cloning, and analysis of an entire genetic material in a given 
marine habitat [13].   
The diversity of marine microbes and their unique environmental properties in extreme conditions 
potentially contribute to the novelty and value of serpin genes. The serpins encoded by these genes may 
exhibit unique characteristics that may be useful in specific therapeutic applications [14,15]. To expand 
the current knowledge on serpins, the present study screened a plasmid metagenomic library [16] 
constructed from marine water samples. The isolated novel serpin gene was overexpressed in 
Escherichia coli. The results demonstrate the ability of metagenomics to be a powerful tool for 
discovering novel pharmaceutical enzymes. The potential for marine microbes to become valuable 
sources of serpins and other industrial enzymes is also proven [17]. To our knowledge, the present study 
is the first report on a serpin gene isolated from a marine metagenome. Mar. Drugs 2011, 9 
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2. Results and Discussion 
2.1. Cloning and Sequence Analysis of a Novel Serpin Gene 
Metagenomics strategies are successfully employed to isolate and identify enzymes with novel 
biocatalytic activities, or secondary metabolites from uncultivable components of microbial 
communities from various environmental samples [18]. A previous study has constructed a plasmid 
library containing approximately 50,000 clones from metagenomic DNA isolated from marine water 
samples [16]. The marine water samples were collected from the South China Sea (21°28′N, 109°07′E). 
The pH, temperature, and salinity of the collected seawater sample were 8.2, 15 °C, and 32‰, 
respectively. Plasmid DNA from randomly picked clones is digested with EcoRІ. Different insert DNAs 
1–15 kb long, with an average of approximately 4.0 kb, are obtained. This result confirms that the marine 
metagenomic library contained DNA molecules from uncharacterized genomes. The marine 
metagenome of naturally occurring microrganisms is also demonstrated to contain an immense pool of 
genes. Most of these genes are not represented in pure and enriched cultures established under certain 
selective conditions [19]. In the present study, a metagenomic library was screened using a 
sequence-based screening strategy. Consequently, an interesting recombinant clone, named pGXAG59, 
was identified. pGXAG59 possibly contained a serpin gene, and had its insert further characterized. The 
insert DNA had a length of 1128 bp, and had no good match with known genes at the DNA level in the 
database. However, insert DNA was most similar with some serpins at the amino acid level. Based on 
the database comparison, the cloned gene on pGXAG59 was considered as novel, and was named Spi1C. 
The gene had a long open reading frame of 642 bp, with a mol% G + C content of 49.92, encoding 
214 amino acids. The predicted relative molecular weight (Mr) was approximately 24 kDa, and the 
isoelectric point was 4.33. These values were consistent with the observed Mr of 20–40 kDa of most 
serpin proteins [20]. Given that the unstable index was 24.90, Spi1C was considered as a relatively 
stable serpin. The deduced amino acid sequence of Spi1C was searched in the National Center for 
Biotechnology Information (NCBI) and Expert Protein Analysis System (ExPaSy) databases. The 
results showed that Spi1C protein shared some moderate similarities with serpins from Salinibacter 
ruber M8 (39% identical and 60% similar) and Spirosoma linguale DSM 74 (43% identical and 57% 
similar). Similarities with three other possible partial proteinase inhibitor I4 serpins were also found. The 
proteinase inhibitor I4 serpins were from Dyadobacter fermentans DSM 18053 (GenBank accession  
No. YP_003088034; 39% identical and 60% similar), from Arthrospira maxima CS-328 (GenBank 
accession No. ZP_03274562; 38% identical and 59% similar), and from Cyanothece sp. PCC 7822 
(GenBank accession No. YP_003888593; 37% identical and 58% similar). A similarity with the 
hypothetical protein BACCELL_01031 (GenBank accession No. ZP_03676704) from Bacteroides 
cellulosilyticus DSM 14838 (36% identical and 60% similar) was also observed. 
Multiple alignments of the deduced amino acids of Spi1C with the most homologous serpin proteins 
(NCBI database) are shown in Figure 1. The alignments revealed that the target enzymes had lower 
overall amino acid homologies with other serpins. The percentages of identity with the serpins from 
bacteria were slightly higher than with those from eukaryotic homologues. The amino acid sequence 
comparison revealed that the deduced Spi1C peptide shared conserved active site residues with other 
bacterial serpin members. An amino acid N-terminal extension presented only in the bacterial serpins 
(Figure 1). Therefore, Spi1C may be classified as a new proteinase inhibitor I4 serpin [21,22]. Mar. Drugs 2011, 9 
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Figure 1. Sequence alignment of Spi1C protein with other bacterial serpins. The serpins 
are identified by their GenBank accession numbers. The sequence similarity searches were 
performed using the Basic Local Alignment Search Tool (BLAST) 2.0 program. The 
amino acid sequence alignment of the target putative protein with homologous proteins 
was performed using the AlignX program, a component of the Vector NTI suite (InforMax, 
North Bethesda, MD, USA), using the blosum62mt2 scoring matrix. P1 denotes the start 
codon of reactive center loop (RCL) conserved domain. The potential RCL sequence 
regions are in boxed.  
 Mar. Drugs 2011, 9 
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A phylogenetic tree based on the neighbor-joining method located the Spi1C protein in a distinct 
clade from the serpins found in other microorganisms (Figure 2). Such a placement suggested a 
relatively high level of divergence from bacterial serpins. The phylogenetic analysis also revealed  
that the Spi1C protein is not distinctively grouped with the eukaryotic homologues. This finding 
reflected the considerable dissimilarities between eukaryotes and prokaryotes. Sequence comparisons 
between the Spi1C protein and other serpins demonstrated differences clustered at the 5′ end of the 
coding sequence [23].   
Figure 2. Phylogenetic relationship of the Spi1C protein with other serpins. The sequence 
alignment was performed using ClustalW version 1.81. The phylogenetic tree was 
constructed by the neighbor-joining method using Molecular Evolutionary Genetics Analysis 
(MEGA) version 4.0. Boot-strapping values were used to estimate the reliability of the 
phylogenetic reconstructions (1000 replicates). The numbers associated with the branches 
refer to bootstrap values (confidence limits) representing the substitution frequencies per 
amino acid residue. The serpins are identified by their GenBank accession numbers. 
 
2.2. Overexpression and Purification of Recombinant Spi1C Protein 
To investigate the biochemical properties of Spi1C, the gene was subcloned in a frame with a 
6-histidine tag sequence into the expression vector pETBlue-2. The clone was then expressed in E. coli 
BL21(DE3)pLysS. The initial analysis of the crude cell lysate showed that the bacteria containing the 
recombinant plasmid pETBlue-2-Spi1C produced a substantial amount of the expected recombinant 
protein. In contrast, this protein was not detectable in the culture of the bacteria containing the parent 
vector pETBlue-2. The cell extracts of Spi1C were subjected to sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE). An increased expression of the ~28 kDa protein was observed in the Mar. Drugs 2011, 9 
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cell extracts of recombinant Spi1C compared with the control. The molecular weights of the proteins 
were similar with those of recombinant Spi1C. Hence, Spi1C was considered as intracellularly expressed 
without any modification. The recombinant Spi1C protein was then purified with nickel-nitrilotriacetic 
acid (Ni-NTA) metal-affinity chromatography (Figure 3). The purified proteins produced a single band 
on the SDS-PAGE gels. Their molecular weights concurred with those deduced from the amino acid 
sequences of the recombinant protein. 
Figure 3. SDS-PAGE of recombinant Spi1C protein. The proteins were separated by  
12% (w/v) SDS-PAGE, and then stained with Coomassie brilliant blue G-250. (A) Lane 1, 
molecular weight standards; lane 2, total protein of E. coli BL21(DE3)pLysS harboring 
empty pETBlue-2 as control; lane 3, total protein of E. coli BL21(DE3)pLysS harboring the 
recombinant spi1C in pETBlue-2 without induction by isopropyl-β-D-thiogalactopyranoside 
(IPTG); and lane 4, total protein of E. coli BL21(DE3)pLysS harboring the recombinant 
Spi1C in pETBlue-2 induced by the addition of 0.5 mM IPTG. The recombinant Spi1C 
protein is indicated by the black arrow; (B) Lane 1, molecular weight standards; lane 2, 
sample purified by the Ni-NTA column method. 
 
2.3. Functional Characterization of Recombinant Spi1C Protein 
Serpin inhibitors commonly contained two types of inhibition-activity and non-inhibition-activity 
members. The activity-serpin inhibitors are effective against the serine and cysteine protease families 
(also including the tissue protease and Cys-Asp families) [1]. The activity-serpin inhibitors (specially the 
Kunitz and Kazal family members) use reactive site loop structure conformational change and 
consequent kinetic trapping of an enzyme intermediate to effect inhibition [24]. To examine the 
inhibitory specificity of the sample to serine proteases, the purified Spi1C protein from a marine 
metagenome was assayed for inhibitory activity against three different proteases of elastase, trypsin, and 
α-chymotrypsin (Figure 4). The purified Spi1C protein inhibited trypsin and α-chymotrypsin, but had no 
effect on elastase. Among the serine proteases, Spi1C protein had inhibitory activity against trypsin, Mar. Drugs 2011, 9 
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with an inhibitory constant Ki of 1.52 × 10
−8 M. However, Spi1C had a comparatively weaker inhibition 
toward α-chymotrypsin, with an inhibitory constant of 1.79 × 10
−8 M. Yang et al. have found a novel 
serine protease inhibitor named bicolin from the venom of Vespa bicolor Fabricius. The Ki of the 
bicolin toward trypsin was 5.5 × 10
−7 M and no inhibition was detected to elastase and α-chymotrypsin, 
respectivley [21]. Lu et al. have also reported that a novel serine protease inhibitor (Bungaruskuni) from 
Bungarus fasciatus venom had a Ki of around 6.1 × 10
−6 M to chymotrypsin [22]. Using different 
concentrations of Spi1C, the Vmax values of trypsin and α-chymotrypsin remained consistent (Figure 5). 
These data indicated that Spi1C was a competitive inhibitor. The specific inhibitor activity of Spi1C to 
trypsin and α-chymotrypsin were 6940 and 3640 U/mg, respectively. Using trypsin as the chromogenic 
substrate, the optimum pH and temperature of Spi1C against trypsin activity were 7.0–8.0 and 25 °C, 
respectively (Figure 6). In 2009, Torres-Castillo et al. have found that the serpin OsTI 2 from  
the seeds of Opuntia streptacantha only inhibits the trypsin-like proteinases present in P. truncatus,  
P. americana, Acheta sp., and Gryllus sp. [20]. 
Figure 4. Inhibition effects of the purified recombinant Spi1C protein against trypsin and 
α-chymotrypsin. Fluorescently labeled trypsin and α-chymotrypsin were incubated with  
340 µmol/L of the indicated enzyme at the optimal reaction conditions, with and without the 
indicated concentration of Spi1C protein, after which the fluorescence was measured. 
 Mar. Drugs 2011, 9 
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Figure 5. (A) Different Lineweaver-Burk plots of the purified recombinant Spi1C protein 
at different concentrations of trypsin substrate at the optimal reaction conditions;   
(B) Different Lineweaver-Burk plots of the purified recombinant Spi1C protein at different 
concentrations of α-chymotrypsin substrate with 50 mM Tris-HCl buffer at pH 7.8 and 
25  °C. The used different concentrations purified recombinant Spi1C protein were  
(■) (68.1 nmol/L); (◆) (45.4 nmol/L); (▲) (22.7 nmol/L); and (●) (0 nmol/L), respectively. 
 Mar. Drugs 2011, 9 
 
 
1495
Figure 6. ( A) Effects of pH (▲) on the inhibitory enzymatic activity of the purified 
recombinant Spi1C protein; (B) Effects of temperature (■) on the inhibitory enzymatic 
activity of the purified recombinant Spi1C protein. The inhibitory activity was assayed as 
described in the Experimental Section. The initial trypsin inhibitory activity assayed  
under standard conditions was considered as 100% relative activity. Values represent the  
mean ± SD of three independent experiments. 
 
Serpins are easily identified by conserved amino acid motifs because of their high degree of 
structural conservation. The relationship between the function and structure of the Spi1C protein is 
interesting. Many kinds of serpins have been separated and characterized from living organisms using 
culture-dependent techniques [1]. In the current study, a novel serpin gene was identified from a marine 
metagenome library. However, some serpins may not have inhibitory activity. In the hinge region in 
the RCL conserved domain, the residues are large and polar (e.g., Lys, Asp, Glu, and Ser); in 
inhibitory serpins, this region is occupied by small residues (e.g., Ala, Thr, and Ser). Laskowski and 
Kato [23] have pointed out that P1 site residues of RSL conserved domain in trypsin inhibitors are 
positively charged residues (Arg or Lys). In the chymotrypsin inhibitor, the residue are usually large and 
hydrophobic (Leu, Phe, or Tyr). The P1-reactive-site residue of the venom basic protease inhibitor IX 
has been identified as Asn17, whereas the same position in 2 RCLs of Spi1C is possible Gly and Phe, Mar. Drugs 2011, 9 
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respectively (Figure 1). Recently, the P1 site residues His and Asn for α-chymotrypsin binding have also 
been reported [10]. The specificity of Kunitz/bovine pancreatic trypsin inhibitors toward serine 
proteases is closely associated with P1 amino acids. However, aside from surrounding the reactive site, 
the residues present in the weak contact loop are also important in different interactions with various 
serine proteases [23,25]. Thr and Leu were often at the P1 and P1’ positions of RCL, and the protein 
contained most of the conserved residues [26,27]. Apart from the strange RCL sequence, Spi1C had 
the inhibitory characteristics of trypsin and α-chymotrypsin. The functional characterization of Spi1C 
may provide new insights into the relationship among the sequence, structure, and activity of known 
serpins [27]. Elucidating the catalytic mechanism via studies of the three-dimensional structures of the 
Spi1C protein using X-ray diffraction methods is an interesting research direction. 
3. Experimental Section  
3.1. Plasmid Vectors, Bacterium Strains, and Growth Conditions    
The protein expression vector used was pETBlue-2. E. coli NovaBlue (Novagen) strain was used as 
the screening host for the pETBlue-2 bearing inserts. The bacterial strain for the expression of the 
recombinant protein was E. coli BL21(DE3)pLysS (Novagen). All E. coli bacterial cultures were grown 
at 37 °C on Luria–Bertani (LB) agar plates or media. Where appropriate, the media were modified with 
100 μg ampicillin/mL, 50 μg carbenicillin/mL, 15 μg tetracycline/mL, or 34 μg chloramphenicol/mL. 
3.2. DNA Manipulation and Protein Analysis 
All DNA manipulations, including cloning and subcloning, transformation of E. coli cells, and 
polymerase chain reaction (PCR), were performed according to standard techniques [28] or following 
the instructions of the manufacturer, unless indicated otherwise. Protein preparation and analysis, 
including protein extraction from E. coli, protein quantification, and SDS-PAGE, were performed as 
described by standard protocols [29]. 
3.3. DNA Sequence Analysis, Database Search, and Gene Structure Characterization 
DNA sequence analysis was performed using the BigDye Terminator Cycle sequencing kit on an ABI 
Prism 3700 DNA analyzer (Applied Biosystems, USA). Protein translation was carried out using the 
web-based translation tool at the ExPaSy homepage [30]. Sequence predictions were retrieved from the 
protein and nucleotide databases at NCBI Entrez page [31]. Sequence similarity searches were 
performed with the BLAST 2.0 program. The amino acid sequence alignment of Spi1C with 
homologous proteins was done using the AlignX program, a component of the Vector NT1 suite 
(InforMax, North Bethesda, MD, USA) using the blosum62mt2 scoring matrix. Based on the 
comparison of the deduced amino acids, a putative gene (Spi1C) encoding a novel serpin was identified 
and further characterized. A phylogenetic tree was constructed using the neighbor-joining method with 
MEGA 4.0 software [32]. Boot-strapping values were used to estimate the reliability of the phylogenetic 
reconstructions (1000 replicates). Mar. Drugs 2011, 9 
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3.4. Overexpression and Purification of the Recombinant Serpin Protein 
The  Spi1C nucleotide sequence was amplified from the plasmid pGXAG59 isolated from a 
serpin-producing clone. PCR was carried out in a total volume of 50 μL containing 2.5 mM MgCl2,  
10 mM Tris-HCl (pH 8.4), 50 mM KCl, 0.2 mM deoxynucleotide triphosphate, 0.4 μM each primer,  
1.0 unit Vent DNA polymerase (NEB, USA), and 10 ng of plasmid template. The restriction enzyme 
sites (underlined) for BamHI and HindIII were designed in the forward primer/reverse primer 
(5′-TTAGGATCCGATGTTCCTTATGAACGCC-3′/5′-ATAAGCTTCTCCGGCTGCATCACTTTC-3′). 
The PCR cycling consisted of denaturation steps (96 °C for 2 min), 30 cycles at 94 °C for 40 s, 58.5 °C 
for 30 s, and 72 °C for 2 min, as well as a final extension step at 72 °C for 10 min. After amplification, 
the PCR product mixture was digested by BamHI as well as HindIII, and directly ligated into the 
pETBlue-2 (Novagen) expression vector cleaved with the same enzymes. The resulting recombinant 
plasmids were transferred into NovaBlue (Novagen) competent cells and placed on LB selection plates. 
After overnight incubation at 37 °C, positive white colonies were picked for the isolation of the 
recombinant expression plasmid. The recombinant expression plasmid was then introduced into E. coli 
BL21(DE3)pLysS to express the target protein. 
The transformed bacterial cells were cultured in an LB medium containing 50 μg carbenicillin/mL 
and 100 μg chloramphenicol/mL at 37 °C. Protein expression was induced by the addition of 1 mM 
isopropyl-β-D-thiogalactopyranoside when the optical density at 600 nm reached 0.6. After incubation 
for an additional 6 h, the cells were harvested, washed twice with phosphate-buffered saline (pH 7.6), 
and lysed by sonication in 10 mL of 20 mM Tris-HCl (pH 8.0). The lysate was centrifuged twice at 
30,000× g for 20 min at 4 °C. About 1 mL of the supernatant was diluted with 5 mL of column buffer 
(20 mM Tris-HCl, pH 8.0, 10 mM imidazole, 300 mM NaCl). The diluted supernatant was then applied 
onto an equilibrated Ni-NTA column containing 1 mL of Ni-NTA-agarose (Novagen). After washing 
with 5 mL of column buffer containing 10 mM imidazole, the recombinant protein was eluted with 
column buffer containing 250 mM imidazole and the target fraction (~600 μL) was collected. 
Immediately after elution from the column, 1,4-dithiothreitol (Promega) was added to the protein 
solution to a final concentration of 5 mM. The protein concentration was determined using a Bio-Rad 
protein assay kit, with bovine serum albumin as the standard. The protein purified with the Ni-NTA 
column was used for enzyme activity assays. 
3.5. Characterization of the Serpin Gene Spi1C 
3.5.1. Elastase Inhibition Assay 
The inhibition effects of Spi1C against the hydrolysis of the synthetic chromogenic substrate elastase 
(final concentration 20 nM) were assayed in 50 mM Tris-HCl (pH 7.8) at 30 °C. The final concentration, 
approximately 0.5 μM of inhibitor, was pre-incubated for 10 min at 30 °C. N-benzoyl-Arg-4- 
nitroanilide-hydrochloride-p-nitroaniline (pNA) (Sigma) was used as a substrate of elastase [33]. The 
reaction was initiated by the addition of the substrate to a final concentration of 0.5 mM. The formation 
of pNA was continuously monitored at 405 nm for 5 min. The effect of the inhibitor was estimated by 
setting the initial velocity obtained in the presence of the enzyme alone (without inhibitor) as 100%. The Mar. Drugs 2011, 9 
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inhibition assay was carried out per above process, and Ki was obtained by the reciprocal plotting of 
the reaction chromogenic substrate concentrations (0–2 mM). 
3.5.2. α-Chymotrypsin Inhibition Assay 
α-Chymotrypsin activity was determined by an adapted method reported by Kang and Fuchs [34] 
with slight modifications. The blank was prepared with a buffer (50 mM Tris-HCl, pH 7.8 at 25 °C), 
and 0.5 mM N-benzoyl-tyrosine ethyl ester (BTEE; Sigma) was used as the substrate. The reaction was 
continuously monitored at 253 nm for 5 min. The effect of the inhibitor was estimated by setting the 
initial velocity as 100%, obtaining the enzyme alone (without the Spi1C protein). The inhibition assay 
was carried out as described above. Ki was obtained by the reciprocal plotting of the reaction velocity 
via inhibitor concentration under different substrate concentrations (0–2 mM). A control enzyme was 
determined using a buffer solution (990 μL) with 10 μL of enzyme (1 mg/mL), and incubating with  
2 mL of BTEE for 3 min. Inhibitory activity was carried out for 3 min at 25 °C, and the residual 
enzymatic activity was measured. 
3.5.3. Trypsin Inhibition Assay 
The multi-reaction assay for trypsin inhibitory activity was based on H-D-Phe-Pip-Arg-pNA 
(S-2238; Kabi Vitrum, Stockholm, Sweden) hydrolysis according to Elanger et al. [35] with slightly 
modifications. One trypsin inhibitory activity unit was defined as the decrease in 0.01 unit of 
absorbance per 15 min at 25 °C. The reaction was initiated by the addition of the substrate to a final 
concentration of 0.5 mM. The formation of pNA was continuously monitored at 405 mM for 5 min. 
The blank was prepared with 50 mM Tris-HCl buffer (pH 7.8) and 0.5 mM S-2238 substrate at 25 °C. 
The enzyme-controlled reaction was investigated under the same conditions with the addition of 
S-2238 (0.5 mM) in deionized H2O incubated for 15 min. The inhibitory activity was determined using 
an aliquot of the enzyme similar with the control reaction with 0.5 μM inhibitor extract. This mixture 
was pre-incubated for 15 min to allow the formation of the proteinase-inhibitor complex before 
substrate addition. Upon substrate addition, hydrolysis was allowed to proceed for 15 min, and the 
remaining activity was measured. The profiles of activity versus pH and activity versus temperature 
were determined using the above standard assay method. All experiments were performed in triplicate. 
To determine the effect of pH on the inhibitory activity of the recombinant Spi1C protein, the inhibitor 
activity was assayed within pH 3.0–8.0 in 50 mM citric acid-sodium citrate buffer, with 50 mM 
Tris-HCl (pH 7.0–8.5) and 100 mM glycine-NaOH (pH 8.5–11.0) buffers under standard conditions. To 
assess the effect of temperature on Spi1C activity, the inhibitor was assayed at various temperatures 
(20–100 °C) in 50 mM Tris-HCl buffer (pH 8.0). The inhibition assay was carried out as described above, 
and Ki was obtained by the reciprocal plotting of the reaction velocity via inhibitor concentration under 
different substrate concentrations (0–2 mM). 
3.6. Nucleotide Sequence Accession Number 
The Spi1C nucleotide sequence was deposited in GenBank under accession number JF815525. Mar. Drugs 2011, 9 
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4. Conclusions 
A novel serpin gene, Spi1C, was identified by the sequence-based screening of a metagenomic library 
from uncultured marine microorganisms. Sequence analysis suggested that the identified gene product 
was related to proteinase inhibitor I4 serpins. Functional characterization demonstrated that the 
recombinant Spi1C protein exhibited comparable inhibitory activity with trypsin and α-chymotrypsin. 
More detailed biochemical characterizations of Spi1C are currently in progress. Identifying a new serpin 
from marine microorganisms emphasizes the advantages of a metagenomic library in cloning novel 
genes via sequence-based screening using E. coli hosts [27,36]. 
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